Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer

Early prediction of non-response is essential in order to avoid inefficient treatments. The objective of this study was to determine the contrast-enhanced ultrasound (CEUS) for early predicting pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in breast cancer patients. Between Ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Juan, Pu, Huan, Jia, Yan, Chen, Chuang, Ke, Xiao-Kang, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
6800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133101/
https://www.ncbi.nlm.nih.gov/pubmed/34106653
http://dx.doi.org/10.1097/MD.0000000000025908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133101/
https://www.ncbi.nlm.nih.gov/pubmed/34106653
http://dx.doi.org/10.1097/MD.0000000000025908

Ejemplares similares